Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of Circular RNA
31 déc. 2024 09h00 HE
|
Altamira Therapeutics Ltd
Hamilton, Bermuda, Dec. 31, 2024 (GLOBE NEWSWIRE) -- Further proof of great versatility of Altamira’s platform for extrahepatic RNA deliveryCircular mRNA significantly increasing protein expression...